News

Share

Updates matching "Childhood Cancer Research"

Childhood cancer bill passes the Senate

March 23, 2018
National

The U.S. Senate just passed the STAR Act, a bipartisan bill that lays the groundwork for new breakthroughs in researching and treating childhood cancer.

Childhood Cancer Research Bill Passes Senate

March 23, 2018
National

The U.S. Senate passed the Childhood Cancer Survivorship, Treatment, Access and Research (STAR) Act. The bipartisan bill would advance pediatric cancer research and increase transparency and expertise for pediatric cancer research at the National Institutes of Health (NIH).

Childhood cancer bill achieves key committee vote

March 2, 2018
National

A bipartisan bill that lays the groundwork for new breakthroughs in understanding and treating childhood cancer is one step closer to becoming a law. The STAR Act passed a key U.S. Senate committee allowing it to move to the full Senate for a vote. This is an important step in

Childhood Cancer Research Bill Moves Forward in Congress

February 28, 2018
National

The bipartisan bill would advance pediatric cancer research and increase transparency and expertise for pediatric cancer research at the National Institutes of Health (NIH). Additionally, the legislation expands research into the long-term side effects of childhood cancer and its treatments

ACS CAN volunteer speaks on Capitol Hill about childhood cancer

October 16, 2017
National

Melissa Horn first knew something was wrong when she lost her voice during her senior year in high school. A visit to the doctor confirmed a diagnosis of Hodgkin’s Lymphoma.

Childhood Cancer Awareness Month - New bill would increase childhood cancer research

September 6, 2017
National

Childhood cancer is the leading cause of disease-related death among children ages one to 19. Breakthroughs in childhood cancer research have led to more and more children surviving their cancer diagnosis, but progress in treating certain types of cancer remains limited. And, children who survive cancer, often must deal with

New law expands drug research for children with cancer

August 30, 2017

The Research to Accelerate Cures and Equity (RACE) for Children Act encourages new research for childhood cancers by changing the drug development process. There are many cancer drugs currently in development, but most are specifically focused on adult cancers. The RACE Act works to ensure that the innovation occurring for

Senate Reauthorizes FDA User Fee Agreements

August 3, 2017
National

The Senate has advanced the U.S. Food and Drug Administration’s (FDA) Reauthorization Act, which expands four separate user fee agreements on new drugs, generic drugs, medical devices, and biosimilars, and includes a provision to maximize the development of therapies for children with cancer.

Proposed NIH Budget Cuts Could Devastate Medical Innovation and Cripple Critical Cancer Research and Prevention Efforts

May 23, 2017
National

The president’s proposed 2018 budget, would decrease the National Institutes of Health budget by 21 percent, decrease the National Cancer Institute budget by 25 percent, cut the Centers for Disease Control and Prevention’s chronic disease program by nearly 20 percent and reduce Medicaid funding by more than $600 billion.